Market Place
Sourcing Support
Theratechnologies Completes Acquisition By Future Pak
25 Sep 2025 //
GLOBENEWSWIRE
Theratechnologies Gets Court OK for Acquisition by Future PaK
16 Sep 2025 //
GLOBENEWSWIRE
Theratechnologies Shareholders Approve Acquisition by Future Pak
12 Sep 2025 //
GLOBENEWSWIRE
ISS and Glass Lewis Back Theratechnologies` Plan with Future Pak
02 Sep 2025 //
GLOBENEWSWIRE
Theratechnologies Files Meeting Materials for CB Biotech Deal
18 Aug 2025 //
GLOBENEWSWIRE
Theratechnologies` Q2 2025 Financial Results Released
09 Jul 2025 //
GLOBENEWSWIRE
CDMO Future Pak snaps up Theratechnologies for $254M
08 Jul 2025 //
FIERCE PHARMA
Theratechnologies to announce Q2 2025 financial performance
03 Jul 2025 //
GLOBENEWSWIRE
Theratechnologies Reports on its Annual Meeting of Shareholders
29 May 2025 //
GLOBENEWSWIRE
Theratechnologies Presents Novel Data at ACTHIV 2025
02 May 2025 //
GLOBENEWSWIRE
Theratechnologies Provides Update on Sale Process
15 Apr 2025 //
GLOBENEWSWIRE
Future Pak Bids $255M for Theratechnologies Acquisition
11 Apr 2025 //
BUSINESSWIRE
Theratechnologies to Announce Q1 2025 Results and Business Update
03 Apr 2025 //
GLOBENEWSWIRE
Theratechnologies Reports Fiscal 2024 Q4 and Full Year Results
26 Feb 2025 //
GLOBENEWSWIRE
Theratechnologies To Report Q4, FY24 Results, Give Business Update
14 Feb 2025 //
GLOBENEWSWIRE
Theratechnologies Announces Resumed Production of EGRIFTA SV®
03 Dec 2024 //
GLOBENEWSWIRE
Theratechnologies Highlights Impact Of EVAF On CVD Risk In HIV
17 Oct 2024 //
GLOBENEWSWIRE
Theratechnologies Reports Strong Q3 2024 Financial Results
10 Oct 2024 //
GLOBENEWSWIRE
Theratechnologies To Present HIV Treatment Data At IDWeek
09 Oct 2024 //
GLOBENEWSWIRE
Theratechnologies Announces Risk of EGRIFTA SV® Supply Disruption
17 Sep 2024 //
GLOBENEWSWIRE
Theratechnologies to Present at Upcoming Investor Conferences
09 Sep 2024 //
GLOBENEWSWIRE
Theratechnologies Reports Q2 2024 Results With Positive Net Income
10 Jul 2024 //
GLOBENEWSWIRE
Theratechnologies To Announce Q2 2024 Financial Results
26 Jun 2024 //
GLOBENEWSWIRE
Theratechnologies Sudocetaxel Data: Efficacy Safety In Solids At Asco24
23 May 2024 //
GLOBENEWSWIRE
Theratechnologies Reports on its Annual Meeting of Shareholders
09 May 2024 //
GLOBENEWSWIRE
Theratechnologies Mails Proxy Circular For Shareholder Meeting
15 Apr 2024 //
GLOBENEWSWIRE
Theratechnologies Reports Q1 2024 Financials and Business Update
10 Apr 2024 //
GLOBENEWSWIRE
Theratechnologies Appoints Elina Tea to its Board of Directors
05 Apr 2024 //
GLOBENEWSWIRE
Theratechnologies to Announce First Quarter 2024 Financial Results
03 Apr 2024 //
GLOBENEWSWIRE
Theratechnologies Announces Update on its Preclinical Oncology Research Program
22 Mar 2024 //
GLOBENEWSWIRE
Theratechnologies Appoints Jordan Zwick to its Board of Directors
21 Mar 2024 //
GLOBENEWSWIRE
Theratechnologies Announces the Resignation of Mr. Alain Trudeau
29 Feb 2024 //
GLOBENEWSWIRE
Theratechnologies Reports Financial Results for Q4 and Full Year of Fiscal 2023
21 Feb 2024 //
GLOBENEWSWIRE
Theratechnologies Announces Publication in Frontiers in Immunology
20 Feb 2024 //
GLOBENEWSWIRE
Theratechnologies to Announce Fourth Quarter & Full Year 2023 Financial Results
06 Feb 2024 //
GLOBENEWSWIRE
Theratechnologies Announces FDA Approval of Trogarzo 90-Second IV Loading Dose
13 Dec 2023 //
GLOBENEWSWIRE
Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award
24 Nov 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Closing of US$25M Public Offering of Common Shares
31 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Pricing of US$25M Public Offering of Common Shares
26 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Proposed Public Offering of Common Shares
25 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Operational Update
24 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Finalization of Amendments
16 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces VAT
13 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin
04 Oct 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Agreement in Principle with Marathon
25 Sep 2023 //
GLOBENEWSWIRE
Theratechnologies to Present at the Cantor Fitzgerald Global Conference 2023
20 Sep 2023 //
GLOBENEWSWIRE
Theratechnologies to Announce Third Quarter 2023 Financial Results
18 Sep 2023 //
GLOBENEWSWIRE
Theratechnologies to Present at Wainwright 25th Annual Investment Conference
07 Sep 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights
05 Sep 2023 //
GLOBENEWSWIRE
Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite
21 Aug 2023 //
PR NEWSWIRE
Theratechnologies Completes 1-for-4 Reverse Stock Split
31 Jul 2023 //
GLOBENEWSWIRE
Theratechnologies Announces Amendments to its Term Loan Facility
28 Jul 2023 //
GLOBENEWSWIRE
Theratechnologies Announces the Resignation of Directors, Mr. Gary Littlejohn
21 Jul 2023 //
GLOBENEWSWIRE
Theratechnologies Announces 1-for-4 Reverse Stock Split
20 Jul 2023 //
GLOBENEWSWIRE
Theratechnologies to lay off R&D staff to offset sales setback
12 Jul 2023 //
FIERCE BIOTECH
Theratechnologies Reports Q2 2023 Financial Results and Business Updates
12 Jul 2023 //
GLOBENEWSWIRE
Theratechnologies to Announce Second Quarter 2023 Financial Results
29 Jun 2023 //
GLOBENEWSWIRE
Theratechnologies Reports on its Annual Meeting of Shareholders
09 May 2023 //
GLOBENEWSWIRE
Theratechnologies Reports Financial Results for First Quarter 2023
12 Apr 2023 //
GLOBENEWSWIRE
Theratechnologies to Announce First Quarter 2023 Financial Results
03 Apr 2023 //
GLOBENEWSWIRE
